Position in FATE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$53,865
+$11,298 QoQ
Shares Held
44,888
+3.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 1.5482979860987347.ToString("F0")%
Shared 0.ToString("F0")%
None 98.45170201390127.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. FATE ranks #251 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,865 | 44,888 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $42,567 | 43,436 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $63,524 | 50,416 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $65,602 | 58,574 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,684,642 | 3,398,283 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,754,774 | 1,669,562 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,430,563 | 1,837,304 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $5,097,853 | 1,554,224 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $12,913,414 | 1,759,321 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $7,751,170 | 2,072,506 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $5,501,767 | 2,595,174 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $12,988,340 | 2,728,643 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,836,654 | 1,725,729 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $14,802,066 | 1,467,004 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $45,564,073 | 2,033,203 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $49,495,743 | 1,997,407 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $72,178,338 | 1,861,706 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $113,068,464 | 1,932,464 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $100,913,988 | 1,702,615 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $136,395,949 | 1,571,563 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $57,525,363 | 697,700 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $54,558,180 | 600,002 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $23,744,376 | 594,055 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $18,118,319 | 528,077 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $10,315,053 | 464,433 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||